v3.24.1.u1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total
Balance (in shares) at Dec. 31, 2022 32,775        
Balance at Dec. 31, 2022 $ 33 $ 550,299 $ 118,892 $ (1,968) $ 667,256
Increase (Decrease) in Stockholders' Equity          
Net income     47,697   47,697
Foreign currency translation adjustments       50 50
Exercise of stock options (in shares) 2        
Exercise of stock options   25     25
Issuance of common stock on restricted stock units, net of shares withheld (in shares) 56        
Issuance of common stock on restricted stock units, net of shares withheld   (3,907)     (3,907)
Stock-based compensation expense   3,199     3,199
Repurchase of common stock (in shares) (107)        
Repurchase of common stock   (1,924) (10,575)   (12,499)
Balance (in shares) at Mar. 31, 2023 32,726        
Balance at Mar. 31, 2023 $ 33 547,692 156,014 (1,918) 701,821
Balance (in shares) at Dec. 31, 2023 32,685        
Balance at Dec. 31, 2023 $ 33 547,189 319,506 (1,846) 864,882
Increase (Decrease) in Stockholders' Equity          
Net income     51,595   51,595
Foreign currency translation adjustments       (1,731) (1,731)
Change in pension obligation, net of tax       5 5
Issuance of common stock on restricted stock units, net of shares withheld (in shares) 42        
Issuance of common stock on restricted stock units, net of shares withheld   (2,699)     (2,699)
Stock-based compensation expense   4,690     4,690
Repurchase of common stock (in shares) (122)        
Repurchase of common stock   (2,201) (12,798)   (14,999)
Balance (in shares) at Mar. 31, 2024 32,605        
Balance at Mar. 31, 2024 $ 33 $ 546,979 $ 358,303 $ (3,572) $ 901,743